Literature DB >> 1316742

Production of angiotensin converting enzyme by rheumatoid synovial membrane.

D Veale1, G Yanni, B Bresnihan, O FitzGerald.   

Abstract

Vascular proliferation and mononuclear cell infiltration are prominent changes observed in synovium from actively inflamed joints of patients with rheumatoid arthritis. Angiotensin converting enzyme (ACE) is a halide activated peptidase produced mainly by endothelial cells and by activated monocytes. It has been proposed that levels of ACE activity in synovial fluid might reflect changes in membrane vascularity, the degree of monocyte infiltration, or the thickness of the lining layer. In this study, ACE activity in serum and synovial fluid samples from 18 patients with inflammatory arthritis was measured and compared with levels in 12 control subjects with non-inflammatory arthritis. Although serum levels were similar in the two groups, ACE activity in synovial fluid was significantly increased in the group with inflammatory arthritis compared with controls (mean (SE) 37 (5) v 19 (3)). Staining of synovial membranes from patients with rheumatoid arthritis with a monoclonal antibody to ACE localised ACE to the endothelium and to mononuclear cells of macrophage origin. ACE activity was then measured in supernatants of synovial membrane from patients with rheumatoid arthritis after one and seven days of culture. A significant increase in ACE activity was observed after seven days of culture (mean (SE) day 1, 17 (5) v day 7, 25 (3)). Levels of ACE activity, however, did not correlate with the lining layer thickness, with the number of macrophages per square millimetre, nor with the number of blood vessels per square millimetre of synovial tissue. No correlation was observed either between levels of ACE in the supernatant of synovial membrane and levels of interleukin 1 or interleukin 6. In conclusion, ACE is produced by the synovial membrane of patients with rheumatoid arthritis and is localised to monocytes and endothelial cells. Levels of activity do not directly reflect membrane vascularity, monocyte or macrophage number, or the thickness of the lining layer.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1316742      PMCID: PMC1004695          DOI: 10.1136/ard.51.4.476

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  25 in total

1.  A continuous spectrophotometric assay for angiotensin converting enzyme.

Authors:  B Holmquist; P Bünning; J F Riordan
Journal:  Anal Biochem       Date:  1979-06       Impact factor: 3.365

2.  Induction of angiotensin converting enzyme in human monocytes in culture.

Authors:  J Friedland; C Setton; E Silverstein
Journal:  Biochem Biophys Res Commun       Date:  1978-08-14       Impact factor: 3.575

3.  Subcellular localization of pulmonary antiotensin-converting enzyme (kininase II).

Authors:  J W Ryan; U S Ryan; D R Schultz; C Whitaker; A Chung
Journal:  Biochem J       Date:  1975-02       Impact factor: 3.857

4.  Morphometric analysis of blood vessels in synovial membranes obtained from clinically affected and unaffected knee joints of patients with rheumatoid arthritis.

Authors:  O FitzGerald; M Soden; G Yanni; R Robinson; B Bresnihan
Journal:  Ann Rheum Dis       Date:  1991-11       Impact factor: 19.103

Review 5.  How important are T cells in chronic rheumatoid synovitis?

Authors:  G S Firestein; N J Zvaifler
Journal:  Arthritis Rheum       Date:  1990-06

6.  Fate of angiotensin I in the circulation.

Authors:  K K Ng; J R Vane
Journal:  Nature       Date:  1968-04-13       Impact factor: 49.962

7.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

Authors:  S M Hsu; L Raine; H Fanger
Journal:  J Histochem Cytochem       Date:  1981-04       Impact factor: 2.479

Review 8.  Immunologic components of granuloma formation. Epithelioid cells, giant cells, and sarcoidosis.

Authors:  W G Spector
Journal:  Ann N Y Acad Sci       Date:  1976       Impact factor: 5.691

9.  Decrease in angiotensin I conversion by acute hypoxia in dogs.

Authors:  P J Leuenberger; S A Stalcup; R B Mellins; L M Greenbaum; G M Turino
Journal:  Proc Soc Exp Biol Med       Date:  1978-09

10.  Angiotensin-converting enzyme: vascular endothelial localization.

Authors:  P R Caldwell; B C Seegal; K C Hsu; M Das; R L Soffer
Journal:  Science       Date:  1976-03-12       Impact factor: 47.728

View more
  14 in total

1.  Angiotensin-converting enzyme (ACE) genotypes and disability in hospitalized older patients.

Authors:  Davide Seripa; Giulia Paroni; Maria G Matera; Carolina Gravina; Carlo Scarcelli; Michele Corritore; Luigi P D'Ambrosio; Maria Urbano; Grazia D'Onofrio; Massimiliano Copetti; Patrick G Kehoe; Francesco Panza; Alberto Pilotto
Journal:  Age (Dordr)       Date:  2010-11-13

Review 2.  Macrophages: An Inflammatory Link Between Angiogenesis and Lymphangiogenesis.

Authors:  Bruce A Corliss; Mohammad S Azimi; Jennifer M Munson; Shayn M Peirce; Walter L Murfee
Journal:  Microcirculation       Date:  2016-02       Impact factor: 2.628

Review 3.  The pathogenesis of ovarian hyperstimulation syndrome: a continuing enigma.

Authors:  A Simon; A Revel; A Hurwitz; N Laufer
Journal:  J Assist Reprod Genet       Date:  1998-04       Impact factor: 3.412

4.  Angiotensin converting enzyme in rheumatoid arthritis.

Authors:  J T Beranek
Journal:  Ann Rheum Dis       Date:  1993-01       Impact factor: 19.103

5.  Renin and angiotensin-converting enzyme (ACE) as active components of the local synovial renin-angiotensin system in rheumatoid arthritis.

Authors:  Veli Cobankara; Mehmet Akif Oztürk; Sedat Kiraz; Ihsan Ertenli; Ibrahim C Haznedaroglu; Salih Pay; Meral Calgüneri
Journal:  Rheumatol Int       Date:  2005-03-11       Impact factor: 2.631

6.  Angiotensin converting enzyme in human synovium: increased stromal [(125)I]351A binding in rheumatoid arthritis.

Authors:  D A Walsh; J Catravas; J Wharton
Journal:  Ann Rheum Dis       Date:  2000-02       Impact factor: 19.103

7.  Angiotensin-converting enzyme inhibitors delay the occurrence of renal involvement and are associated with a decreased risk of disease activity in patients with systemic lupus erythematosus--results from LUMINA (LIX): a multiethnic US cohort.

Authors:  S Durán-Barragán; G McGwin; L M Vilá; J D Reveille; G S Alarcón
Journal:  Rheumatology (Oxford)       Date:  2008-05-29       Impact factor: 7.580

8.  Angiotensin-converting enzyme gene polymorphism in patients with psoriatic arthritis.

Authors:  Adel M Al-Awadhi; Eman A Hasan; Prem N Sharma; M Zafaryab Haider; Khaled Al-Saeid
Journal:  Rheumatol Int       Date:  2007-04-14       Impact factor: 2.631

Review 9.  Angiotensin II in inflammation, immunity and rheumatoid arthritis.

Authors:  Y Chang; W Wei
Journal:  Clin Exp Immunol       Date:  2015-02       Impact factor: 4.330

10.  An Extensive Study of the Functional Polymorphisms of Kinin-Kallikrein System in Rheumatoid Arthritis Susceptibility.

Authors:  Anthoula Chatzikyriakidou; Paraskevi V Voulgari; Alexandros A Drosos
Journal:  Arch Rheumatol       Date:  2017-09-13       Impact factor: 1.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.